SpeakEasy Signs a MOU to Bring Premium Cannabis to Germany and the European Union with HerbaMedica GmbH

Vancouver, B.C., – Speakeasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the “Company” or “SpeakEasy”) a late stage ACMPR applicant is pleased to announce it has signed a memorandum of understanding with HerbaMedica GmbH to export premium cannabis to Germany and the EU markets.

HerbaMedica will buy/distribute a fixed amount of products from SpeakEasy and SpeakEasy will provide this amount every year, initially this obligation shall last for three years after the binding conclusion of the Venture. binding conclusion of the Venture. The before mentioned amount shall be fixed between the parties once the German authorities have granted the license, companies will engage in signing a definitive agreement, with further in-depth details being provided, independent from the allowed amounts according to that license. In the before mentioned period of initially three years Partner will only distribute or sell Products to or in Germany and the EU via HerbaMedica. “By having HerbaMedica distribute our products throughout the EU, we gain access to a significant amount of possible clientele. Currently there are only 7 approved Cannabis importers to Germany, Speakeasy is excited to be a applicant for this opportunity to join this group of selected few.

HerbaMedica plans to give SpeakEasy access to the German and EU market (to the extent that the latter is included in the access to the German market) with applying and paying for their inspection. The inspection will consist of two stages. Initially a specialised Consulting Company regarding the EU GMP (Good Manufacturing Practice) and EU GACP (Good Agricultural Cultivation Practice) will inspect the sites and advise on necessary improvements / changes to receive the EU license. Thereafter the sites will be inspected by the competent German authorities. Theexternal costs for the inspection will be borne by HerbaMedica, internal preparation / improvement costs of SpeakEasy will remain with the SpeakEasy.

“SpeakEasy is a great fit for Herba Medica because of the extensive knowledge Marc and his team bring to the table in all facets of the cannabis industry. Both our companies specialties are very complimentary to each other.” – Stated HerbaMedica CEO David Hohne

About HerbaMedica:

HerbaMedica is late stage applicant for importing cannabis into Germany. It was founded in Summer 2017 to become a importer of premium cannabis flower and cannabis based products to Germany and the European Union. Currently there are seven importers which are all importing from the same sources into the German market.

ON BEHALF OF SPEAKEASY CANNABIS CLUB LTD.
(signed) “Marc Geen”
Chief Executive Officer
For further information, please contact:
Speakeasy Cannabis Club Ltd.
www.speakeasygrowers.com
Telephone: 604-283-1722

Not for distribution to United States wire services or dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.
Statements about the Target’s future facility expansion plans or ACMPR license application are all forward-looking information.

Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include failure to obtain regulatory approval, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.
Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Share this post